Livforsakringsbolaget Skandia’s AMAG Pharmaceuticals AMAG Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-38,800	Closed	-$365K	–	684
2020 Q3	$365K	Hold	38,800	–	–	0.04%	284
2020 Q2	$297K	Hold	38,800	–	–	0.03%	314
2020 Q1	$240K	Hold	38,800	–	–	0.03%	306
2019 Q4	$472K	Hold	38,800	–	–	0.06%	232
2019 Q3	$448K	Hold	38,800	–	–	0.05%	259
2019 Q2	$388K	Hold	38,800	–	–	0.05%	273
2019 Q1	$500K	Hold	38,800	–	–	0.07%	225
2018 Q4	$589K	Hold	38,800	–	–	0.09%	191
2018 Q3	$776K	Sell	38,800 -7,800	-17%	-$178K	0.09%	191
2018 Q2	$909K	Hold	46,600	–	–	0.08%	218
2018 Q1	$939K	Hold	46,600	–	–	0.09%	204
2017 Q4	$617K	Sell	46,600 -3,000	-6%	-$45.2K	0.06%	283
2017 Q3	$915K	Hold	49,600	–	–	0.08%	237
2017 Q2	$912K	Hold	49,600	–	–	0.08%	241
2017 Q1	$1.12M	Buy	49,600 +11,200	+29%	+$268K	0.1%	200
2016 Q4	$1.34K	Buy	+38,400	New	+$1.15M	0.07%	298

Livforsakringsbolaget Skandia's AMAG Position: Q4 2020 in Review

Livforsakringsbolaget Skandia sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 38,800 shares — an estimated $365K sold.

Livforsakringsbolaget Skandia first reported a position in AMAG in Q4 2016 and held it in 16 quarters. The position peaked at $1.12M in Q1 2017. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

Livforsakringsbolaget Skandia reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Livforsakringsbolaget Skandia sold 38,800 AMAG Pharmaceuticals shares in Q4 2020, an estimated $365K.
Livforsakringsbolaget Skandia first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 16 quarters.
Livforsakringsbolaget Skandia's AMAG Pharmaceuticals position peaked at $1.12M in Q1 2017.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2020, filed 2 Mar 2021.